Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells

NACompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
Infertility
Interventions
PROCEDURE

Intrauterine administration of hCG-activated peripheral blood mononuclear cells

Administration of hCG-activated peripheral blood mononuclear cells in the uterine cavity of the patient

PROCEDURE

Intrauterine administration of sperm washing medium

Administration of sperm washing medium instead of PBMC in the uterine cavity of the patient

Trial Locations (1)

H7S1Z5

Fertilys inc., Laval

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Institut National de la Recherche Scientifique - Centre Armand Frappier Santé Biotechnologie

UNKNOWN

lead

Fertilys

INDUSTRY

NCT04648566 - Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells | Biotech Hunter | Biotech Hunter